Skip to main content
SpringerLink
Log in

Renal disease associated with illicit drug abuse

  • Chapter
Clinical Nephrotoxins

  • 341 Accesses

Abstract

The illicit use of drugs involves many millions of people worldwide. The abuse of each drug is associated with a variety of medical complications. In recent years, abuse of both heroin and cocaine have been major problems worldwide. Other illicit agents, however, which continue to induce medical complications include barbiturates, ethyl alcohol, amphetamines, and phencyclidine, as well as drug combinations. There are a number of renal disorders associated with drug abuse. Some may be related to nephrotoxicity associated with the drugs themselves, e.g. heroin nephropathy, while others are caused by complications related to drug abuse, e.g. post-infectious glomerulonephritis and hepatitis related glomerulonephritis developing in intravenous drug addicts.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Avram MM, Iancu M, Weiss S. Heroin usage nephropathy — subclinical to end stage nephrotic syndrome. J Am Soc Nephrol 1971; 5A.

    Google Scholar 

  2. Eknoyan G, Gyorkey F, Dichoso C, Hyde SE, Gyorkey P, Suki WN, Matinez-Maldonado M. Renal involvement in drug abuse. Arch Intern Med 1973; 132: 801–6.

    PubMed  CAS  Google Scholar 

  3. Friedman EA, Rao TKS, Nicastri AD. Heroin-associated nephropathy. Nephron 1974; 13: 421–6.

    PubMed  CAS  Google Scholar 

  4. Kilcoyne MM, Gocke DJ, Meltzer JI, Daly JJ, Thomason GE, Hsu KC, Tannenbaum M. Nephrotic syndrome in heroin addicts. Lancet 1972; 1: 17–20.

    PubMed  CAS  Google Scholar 

  5. Matalon R, Katz L, Gallo G. Glomerular sclerosis in adults with nephrotic syndrome. Ann Int Med 1974; 80: 488–95.

    PubMed  CAS  Google Scholar 

  6. McGinn JT, McGinn TG, Cherubin CE, Hoffman RS. Nephrotic syndrome in drug addicts. NY State J Med 1974; 74; 92–5.

    CAS  Google Scholar 

  7. Rao TKS, Nicastri AD, Friedman EA. A natural history of heroin associated nephropathy. N Engl J Med 1974; 290: 19–23.

    PubMed  CAS  Google Scholar 

  8. Sapira JD, Ball JC, Penn H. Causes of death among institutional narcotic addicts. J Chronic Dis 1970; 22: 733–42.

    PubMed  CAS  Google Scholar 

  9. Salomon MI, Poon TP, Goldblatt M, Tchertkoff V. Renal lesions in heroin addicts: a study based on kidney biopsies. Nephron 1972; 9: 356–63.

    PubMed  CAS  Google Scholar 

  10. Arruda JAL, Kurtzman NA, Pillay VKG. Prevalence of renal disease in asymptomatic heroin addicts. Arch Intern Med 1975; 135: 535–7.

    PubMed  CAS  Google Scholar 

  11. Llach F, Descoeudres C, Massry SG. Heroin associated nephropathy: clinical and histological studies in 19 patients. Clin Nephrol 1979; 11: 7–12.

    PubMed  CAS  Google Scholar 

  12. Thompson AM, Anthonovych T, Lin R. Focal membranoproliferative glomerulonephritis in heroin users. J Am Soc Nephrol 1973; 105A.

    Google Scholar 

  13. Treser G, Cherubin C, Lonergan ET, Yoshizawa N, Viswanathan V, Tannenberg AM, Pompa D, Lange K. Renal lesions in narcotic addicts. Am J Med 1974; 57: 687–94.

    PubMed  CAS  Google Scholar 

  14. Gallo G, Neugarten J, Buxbaum J, Katz L. Renal amyloidosis in subcutaneous heroin abusers. ASN (New Orleans) 1985; 38A.

    Google Scholar 

  15. Brus I, Steiner G, Maceda A, Lejano R. Amyloid fibrils in urinary sediment. Heroin addiction with renal amyloidosis. NY State J Med 1979; 79: 768–71.

    CAS  Google Scholar 

  16. Dubrow A, Mittman N, Ghali V, Ghali V, Flamenbaum W. The changing spectrum of heroin-associated nephropathy. Am J Kidney Dis 1985; 5: 36–41.

    PubMed  CAS  Google Scholar 

  17. Jacob H, Charytan C, Rascoff JH, Golden R, Janis R. Amyloidosis secondary to drug abuse and chronic skin suppuration. Arch Intern Med 1978; 138: 1150–1.

    PubMed  CAS  Google Scholar 

  18. Meador KH, Sharon Z, Lewis EJ. Renal amyloidosis and subcutaneous drug abuse. Ann Intern Med 1979; 91: 565–7.

    PubMed  CAS  Google Scholar 

  19. Novick DM, Yancovitz SR, Weinberg PG. Amyloidosis in parenteral drug abusers. Mt Sinai J Med 1979; 46: 163–7.

    PubMed  CAS  Google Scholar 

  20. Scholes JV, Derosena R, Appel GB. Amyloidosis and the nephrotic syndrome in chronic heroin addicts. Proc 7th Int Congr Nephrol 1978; L9.

    Google Scholar 

  21. Scholes J, Derosena R, Appel GB, Ao W, Boyd MT, Pirani CL. Amyloidosis in chronic heroin addicts with the nephrotic syndrome. Ann Intern Med 1979; 91: 26–9.

    PubMed  CAS  Google Scholar 

  22. Kunis C, Olesnicky M, Nurse H. Heroin nephropathy-clinical pathologic correlations. Proc 9th Int Congr Nephrol 1984; 102A.

    Google Scholar 

  23. Menchel S, Cohen D, Gross E, Frangione B, Gallo G. AA protein-related renal amyloidosis in drug addicts. Am J Pathol 1983; 112: 195–9.

    PubMed  CAS  Google Scholar 

  24. D’Agati V, Cheng JI, Carbone L, Cheng JT, Appel G. The pathology of HIV-nephropathy: a detailed morphologic and comparative study. Kidney Int 1989; 35: 1358–70.

    PubMed  Google Scholar 

  25. Cunningham EE, Brentjens JR, Zielezny MA, Andres GA, Venuto RC. Heroin nephropathy — a clinicopathologic and epidemiologic study. Am J Med 1980; 68: 47–53.

    PubMed  CAS  Google Scholar 

  26. Cunningham EE, Zielezny MA, Venuto RC. Heroinassociated nephropathy — a nationwide problem. JAMA 1983; 250: 2935–6.

    PubMed  CAS  Google Scholar 

  27. Davis JS, Lie JT. Extracellular glomerular microparticles in nephrotic syndrome of heroin users. Arch Pathol 1975; 99: 278–82.

    PubMed  CAS  Google Scholar 

  28. Gardiner H, Mahajan S, Briggs W. Renal disease in heroin addicts. J Am Soc Nephrol 1977; 15A.

    Google Scholar 

  29. Grishman E, Churg J. Focal glomerular sclerosis in nephrotic patients. An electron microscope study of glomerular podocytes. Kidney Int 1975; 7: 111–22.

    PubMed  CAS  Google Scholar 

  30. Grishman E, Churg J, Porush JG. Glomerular morphology in nephrotic heroin addicts. Lab Invest 1976; 35: 415–24.

    PubMed  CAS  Google Scholar 

  31. Rao TKS, Nicastri AD, Friedman EA. Renal consequences of narcotic abuse. Adv Nephrol 1979; 7: 261–90.

    Google Scholar 

  32. Baldwin DS, Gallo GR, Neugarten J. Drug abuse with narcotics and other agents in diseases of the kidney. In: Schrier RW, Gottschalk CW, editors. Diseases of the kidney, 5th ed. Boston: Little Brown and Co, 1992: 1219–36.

    Google Scholar 

  33. Glicklich D, Haskell L, Senitzer D, Weiss RA. Possible genetic predisposition to idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 1988; 12: 26–30.

    PubMed  CAS  Google Scholar 

  34. Haskell LP, Glicklich D, Senitzer D. HLA associations in heroin-associated nephropathy. Am J Kidney Dis 1988; 12: 45–50.

    PubMed  CAS  Google Scholar 

  35. Brown SM, Stimmel B, Taub RN, Kochwa S, Rosenfield RE. Immunologic dysfunction in heroin addicts. Arch Intern Med 1974; 134: 1001–6.

    PubMed  CAS  Google Scholar 

  36. Ringle DA, Herndon BL. In-vitro morphine binding by sera from morphine-treated rabbits. J Immunol 1972; 109: 174–5.

    PubMed  CAS  Google Scholar 

  37. Ryan JJ, Parker CW, Williams RC. Gamma-globulin binding of morphine in heroin addicts. J Lab Clin Med 1972; 80: 155–64.

    PubMed  CAS  Google Scholar 

  38. Weksler ME, Cherubin C, Kilcoyne M, Koppel G, Yoel M. Absence of morphine-binding activity in serum from heroin addicts. Clin Exp Immunol 1973; 13: 613–7.

    PubMed  CAS  Google Scholar 

  39. Singhal PC, Gibbons N, Abromovici M. Long term effects of morphine on mesangial cell proliferation and matrix synthesis. Kidney Int 1992; 41: 1560–70.

    PubMed  CAS  Google Scholar 

  40. May DC, Helderman JH, Eigenbrodt EH, Silva FJ. Chronic sclerosing glomerulopathy (heroin-associated nephropathy) in intravenous T’s and blues abusers. Am J Kidney Dis 1986; 8: 404–9.

    PubMed  CAS  Google Scholar 

  41. Marchand C, Cantin M, Cote M. Evidence for the nephrotoxicity of morphine sulfate in rats. Can J Physiol Pharmacol 1969; 47: 649–55.

    PubMed  CAS  Google Scholar 

  42. Johnson JE, White JJ, Walovitch RC, London ED. Effects of morphine on rat kidney glomerular podocytes. A scanning electron microscope study. Drug Alcohol Depend 1987; 19: 249–57.

    PubMed  CAS  Google Scholar 

  43. Moody C, Kaufman R, McGuire D, Grossman S. The role of adulterants in heroin nephropathy. NKF (New Orleans) 1985; 32.

    Google Scholar 

  44. Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 669–73.

    PubMed  CAS  Google Scholar 

  45. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Ped Nephrol 1990; 4: 303–7.

    CAS  Google Scholar 

  46. Banfi G, Moriggi M, Sabadini E, Felling G, D’Amico G, Ponticelli G. The impact of prolonged immunosuppression of the outcome of idiopathic focal segmental glomerulosclerosis with nephrotic syndrome in adults: a collaborative retrospective study. Clin Nephrol 1991; 36: 53–9.

    PubMed  CAS  Google Scholar 

  47. Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional glomerulonephritis registry study. Am J Med 1987; 82: 938–44.

    PubMed  CAS  Google Scholar 

  48. Ross G, Weinstein S, Dutton S, Whittier FC. Renal transplantation in end stage renal disease of drug abuse. J Urol 1983; 129: 14–5.

    PubMed  Google Scholar 

  49. Gordon MJ, White R, Matas A, Tellis VA, Glicklich D, Quinn T, Soberman R, Veith FJ. Renal transplantation in patients with history of heroin abuse. Transplantation 1986; 42: 556–7.

    PubMed  CAS  Google Scholar 

  50. Amigo JS, Orriols J, Modol J. Resolution of nephrotic syndrome secondary to heroin-associated renal amyloidosis. Nephrol Dial Transplant 1990; 158.

    Google Scholar 

  51. Crowley S, Feinfeld DA, Janis R. Resolution of nephrotic syndrome and lack of progression of heroin associated renal amyloidosis. Am J Kidney Dis 1989; 13: 333–5.

    PubMed  CAS  Google Scholar 

  52. Derosena R, Koss MN, Pirani CL. Demonstration of amyloid fibrils in urinary sediment. N Engl J Med 1975; 293: 1131–3.

    PubMed  CAS  Google Scholar 

  53. Neugarten J, Gallo GR, Buxbaum J, Katz LA, Rubens-tein J, Baldwin DS. Amyloidosis in subcutaneous heroin abusers. Am J Med 1986; 81: 635–40.

    PubMed  CAS  Google Scholar 

  54. Appel GB, Nicolaides M. HIV-AIDS nephropathy in the inner city. New York State J Med 1991; 91: 207–10.

    CAS  Google Scholar 

  55. Rao TK, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987; 316: 1062–8.

    PubMed  CAS  Google Scholar 

  56. Carbone L, D’Agati V, Cheng J-T, Appel GB. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 1989; 87: 389–95.

    PubMed  CAS  Google Scholar 

  57. Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Moskowitz L, Hensley GT, Bourgoignie JJ. Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 429–34.

    PubMed  CAS  Google Scholar 

  58. Strauss J, Abibol C, Zilleruelo G, Scott G, Paredes A, Malaga S, Montane B, Mitchell C. Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med 1989; 321: 625–30.

    PubMed  CAS  Google Scholar 

  59. Bourgoigne JJ. Renal complications of human immuodeficiency virus type I. Kidney Int. 1990; 37: 1571–84.

    Google Scholar 

  60. Seney FD, Burns DK, Silva FG. Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis 1990; 16: 1–13.

    PubMed  Google Scholar 

  61. Glassock RJ, Cohen AH, Danovitch G, Parsa P. Human immunodeficiency virus infection and the kidney. Ann Int Med 1990; 112: 35–49.

    PubMed  CAS  Google Scholar 

  62. Pardo V, Meneses R, Ossa L, Jaffe DJ, Strauss J, Roth D, Bourgoignie JJ. AIDS-related glomerulopathy: occurrence in specific risk groups. Kidney Int 1987; 31: 1167–73.

    PubMed  CAS  Google Scholar 

  63. Cohen AH, Sun NCJ, Shapshak P, Imagawa DT. Demonstration of HIV in renal epithelium in HIV associated nephropathy. Modern Path 1989; 2: 125–8.

    CAS  Google Scholar 

  64. Kimmel PL, Ferreira-Centeno A, Farkas-Szallasi T, Abraham AA, Garrett CT. Viral DNA in microdissected renal biopsy material from HIV infected patients with the nephrotic syndrome. Kidney Int 1993; 43: 1347–52.

    PubMed  CAS  Google Scholar 

  65. Green DF, Resnick L, Bourgoignie J. HIV infects glomerular endothelial and mesangial cells but not epithelial cells in vitro. Kidney Int 1992; 41: 956–60.

    PubMed  CAS  Google Scholar 

  66. Kopp JB, Klotman ME, Adler SH, Bruggeman LA, Dickie P, Marinos NJ, Eckhaus M, Bryant JL, Notkins AL, Klotman PE. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for HIV type 1 genes. Proc Nat Acad Sci 1992; 89: 1577–81.

    PubMed  CAS  Google Scholar 

  67. Koffler A, Friedler RM, Massry SG. Acute renal failure due to nontraumatic rhabdomyolysis. Ann Intern Med 1976; 85: 23–8.

    PubMed  CAS  Google Scholar 

  68. Penn AS, Rowland LP, Fraser DW. Drugs, coma, and myoglobinuria. Arch Neurology 1972; 26: 336–44.

    CAS  Google Scholar 

  69. Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med 1974; 291: 807–11.

    PubMed  CAS  Google Scholar 

  70. Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 1988; 148: 1553–7.

    PubMed  CAS  Google Scholar 

  71. Eneas JF, Schoenfeld PY, Humphreys MH. The effect of infusion of mannitol-sodium bicarbonate on the clinical course of myoglobinuria. Arch Intern Med 1979; 139: 801–5.

    PubMed  CAS  Google Scholar 

  72. Robinson SF, Woods AH. Heroin induced rhab-domyolysis and acute renal failure: a case report. Arizona Med 1974; 31: 246–51.

    PubMed  CAS  Google Scholar 

  73. Richter RW, Challenor YB, Pearson J, Kagen LJ, Hamilton LL, Ramsey WH. Acute myoglobinuria associated with heroin addiction. JAMA 1971; 216: 1172–6.

    PubMed  CAS  Google Scholar 

  74. Rao TK, Nicastri AD, Friedman EA. Natural history of heroin associated nephropathy. In: Hamburger J, Crosnier J, Maxwell MH, editors. Nephrology. New York: Wiley, 1979: 843–56.

    Google Scholar 

  75. Corwin HL, Schreiber MJ, Fang LS. Low fractional excretion of sodium. Occurrence with hemoglobinuric and myoglobinuric-induced acute renal failure. Arch Intern Med 1984; 144: 981–2.

    PubMed  CAS  Google Scholar 

  76. Llach F, Felsenfeld AJ, Haussler MR. The pathophysiology of altered calcium metabolism in rhab-domyolysis-induced acute renal failure. N Engl J Med 1981; 305: 117–23.

    PubMed  CAS  Google Scholar 

  77. Gabow PA, Kaehny WD, Kelleher SP The spectrum of rhabdomyolysis. Medicine 1982; 61: 141–52.

    PubMed  CAS  Google Scholar 

  78. Penn AS. Myoglobin and myoglobinuria. Vinken PJ, Bruyn GW, editors. The handbook of clinical neurology — disease of muscle. Amsterdam, New York, Oxford: North-Holland Publishing Co. 1979; 41: 259–85.

    Google Scholar 

  79. Rowland LP, Penn AS. Myoglobinuria. Med Clin N Am 1972; 56: 1233–56.

    CAS  Google Scholar 

  80. Zager RA. Studies of mechanisms and protective maneuvers in myoglobinuric acute renal failure. Lab Invest 1989; 60: 619–29.

    PubMed  CAS  Google Scholar 

  81. Better OS. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 1990; 322: 825–8.

    PubMed  CAS  Google Scholar 

  82. Venuto RC. Pigment-associated acute renal failure: is the water clearer 50 years later? J Lab Clin Med 1992; 119: 452–4.

    PubMed  CAS  Google Scholar 

  83. Odeh M. The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Engl J Med 1991; 324: 1417–22.

    PubMed  CAS  Google Scholar 

  84. Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt, Rosenberg ME. Induction of heme oxidase is a rapid protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267–70.

    PubMed  CAS  Google Scholar 

  85. Zager RA. Combined mannitol and desferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications. J Clin Invest 1992; 90: 711–9.

    PubMed  CAS  Google Scholar 

  86. Ron D, Taitelman U, Michaelson M, Bar-Joseph G, Bursztein S, Better OS. Prevention of acute renal failure in traumatic rhabdomyolysis. Arch Intern Med 1984; 144: 277–80.

    PubMed  CAS  Google Scholar 

  87. Steinmuller DR, Bolton WK, Stillman MM, Couser WG. Chronic interstitial nephritis and mixed cryoglobulin associated with drug abuse. Arch Pathol Lab Med 1979; 103: 63–6.

    PubMed  CAS  Google Scholar 

  88. McAllister CJ, Horn R, Havron A. Abramson JH. Granulomatous interstitial nephritis: a complication of heroin abuse. S Med J 1979; 72: 162–5.

    CAS  Google Scholar 

  89. Rubin RB, Neugarten J. Medical complications of cocaine: changes in pattern of use and spectrum of complications. Clin Toxicology 1992; 30: 1–12.

    CAS  Google Scholar 

  90. Adverse effects of cocaine abuse. Med Letter 1984; 26: 51–2.

    Google Scholar 

  91. Cregler LI, Mark H. Medical complications of cocaine abuse. N Engl J Med 1986; 315: 1495–500.

    PubMed  CAS  Google Scholar 

  92. Isner JM, Estes NA, Thompson PD, Costanzo-Nordin MR, Subramanian R, Miller G, Katsas G, Sweeney K, Sturner WQ. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986; 315: 1438–43.

    PubMed  CAS  Google Scholar 

  93. Zamoa-Quezada JC, Dinerman H, Stadecker MJ, Kelly JJ. Muscle and skin infarction after free-basing cocaine (Crack). Ann Intern Med 1988; 108: 564–6.

    Google Scholar 

  94. Krohn KD, Slowman-Kovacs S, Leapman SB. Cocaine and rhabdomyolysis. Ann Intern Med 1988; 108: 639–40.

    PubMed  CAS  Google Scholar 

  95. Rubin RB, Neugarten J. Cocaine-induced rhabdomyolysis masquerading as myocardial ischemia. Am J Med 1989; 86: 551–3.

    PubMed  CAS  Google Scholar 

  96. Lombard J, Wong B, Young JH. Acute renal failure due to rhabdomyolysis associated with cocaine toxicity. West J Med 1988; 148: 466–8.

    PubMed  CAS  Google Scholar 

  97. Herzlich BC, Arsura EL, Pagala M, Grob D. Rhabdomyolysis related to cocaine abuse. Ann Intern Med 1988; 109: 335–6.

    PubMed  CAS  Google Scholar 

  98. Pogue VA, Nurse HM. Cocaine-associated acute myoglobinuric renal failure. Am J Med 1989; 86: 183–6.

    PubMed  CAS  Google Scholar 

  99. Merigian KS, Roberts JR. Cocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failure. Clin Toxicol 1987; 25: 135–48.

    CAS  Google Scholar 

  100. Faulkner M, Singhal P, Peters A. Rhabdomyolysis and acute renal failure following cocaine abuse. Kidney Int 1989; 35: 225A.

    Google Scholar 

  101. Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoignie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med 1988; 319: 673–7.

    PubMed  CAS  Google Scholar 

  102. Singhal PC, Rubin RB, Peters A, Santiago A, Neugar-ten J. Rhabdomyolysis and acute renal failure associated with cocaine abuse. Clin Toxicology 1990; 28: 321–30.

    CAS  Google Scholar 

  103. Barrido DT, Joseph AJ, Rao TK, Friedman EA. Renal disease associated with acute and chronic “Crack” abuse. Kidney Int 1988; 33: 181A.

    Google Scholar 

  104. Sharff JA. Renal infarction associated with intravenous cocaine use. Ann Emerg Med 1984; 13: 1145–7.

    PubMed  CAS  Google Scholar 

  105. Cogen FC, Rigg G, Simmons JL, Domino EF. Phencyclidine-associated acute rhabdomyolysis. Ann Intern Med 1978; 88: 210–2.

    PubMed  CAS  Google Scholar 

  106. Akmal M, Valdin JR, McCarron MM, Massry SG. Rhabdomyolysis with and without acute renal failure in patients with phencyclidine intoxication. Am J Nephrol 1981; 1: 91–6.

    PubMed  CAS  Google Scholar 

  107. Hoogwerf B, Kern J, Bullock M, Comty CM. Phencyclidine-induced rhabdomyolysis and acute renal failure. Clin Toxicol 1979; 14: 47–53.

    PubMed  CAS  Google Scholar 

  108. Patel R, Ansari A, Hughes JL. Myoglobinuric acute renal failure associated with phencyclidine abuse. West J Med 1979; 131: 244–7.

    PubMed  CAS  Google Scholar 

  109. Patel R, Das M, Patazzolo M, Ansari A, Balasub-ramaniam J. Myoglobinuric acute renal failure in phencyclidine overdose. Report of observations in eight cases. Ann Emerg Med 1980; 9: 549–53.

    PubMed  CAS  Google Scholar 

  110. Barton CH, Sterling ML, Vaziri ND. Rhabdomyolysis and acute renal failure associated with phencyclidine intoxication. Arch Intern Med 1980; 140: 568–9.

    PubMed  CAS  Google Scholar 

  111. Kuncl RW, Meltzer HY. Pathologic effect of phencyclidine and restraint on rat skeletal muscle: prevention by prior denervation. Exp Neurology 1974; 45: 3887–402.

    Google Scholar 

  112. D’Agati V, Appel GB. Polyarteritis nodosa, Wegener’s granulomatosis, Churg-Strauss syndrome, temporal arteritis, Takayasu’s arteritis, and lymphomatoid granulomatosis. In: Tisher CC, Brenner BH, editors. Renal pathology, 2nd ed. Philadelphia: JB Lippincott Company, 1994: 1087–154.

    Google Scholar 

  113. Citron BP, Halpern M, McCarron M, Lundberg GD, McCormick R, Pincus IJ, Tatter D, Haverback BJ. Necrotizing angiitis associated with drug abuse. N Engl J Med 1970; 283: 1003–11.

    PubMed  CAS  Google Scholar 

  114. Baden MM. Angiitis in drug abuse. N Engl J Med 1971; 284: 111–2.

    Google Scholar 

  115. Citron BP, Peters RL. Angiitis in drug abuse. N Engl J Med 1971; 284: 112.

    Google Scholar 

  116. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lock-shin M, Christian CL. Association between polyarteritis and Australia antigen. Lancet 1970; 2: 1149–53.

    PubMed  CAS  Google Scholar 

  117. Koff RS, Widrich WC, Robbins AH. Necrotizing angiitis in a methamphetamine user with hepatitis B. N Engl J Med 1973; 288: 946–7.

    PubMed  CAS  Google Scholar 

  118. Lignelli GJ, Buchheit WA. Angiitis in drug abuse. N Engl J Med 1971; 284: 112–3.

    Google Scholar 

  119. Cacoub P, Lunel-Fabiani F, Huong Dup LT. Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992; 116: 605–6.

    PubMed  CAS  Google Scholar 

  120. Ginsberg MD, Hetrzman M, Schmidt-Nowara WW. Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. Ann Intern Med 1907; 73: 81–5.

    Google Scholar 

  121. Kendrick WC, Hull AR, Knochel JP. Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med 1977; 86: 381–7.

    PubMed  CAS  Google Scholar 

  122. Foley RJ, Kapatkin K, Verani R, Weinman E. Amphetamine-induced acute renal failure. Southern Med J 1984; 77: 258–60.

    CAS  Google Scholar 

  123. De Marchi S, Cecchin E, Basile A. Renal tubular dysfunction in chronic alcohol abuse — effects of abstinence. N Engl J Med 1993; 329: 1927–34.

    PubMed  Google Scholar 

  124. Sadjadi SA, McLaughlin K, Shah RM. Allergic interstitial nephritis due to Diazepam. Arch Intern Med 1987; 141: 579–80.

    Google Scholar 

Download references

Authors
  1. Cheryl L. Kunis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerald B. Appel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Nephrology and Hypertension, University of Antwerp, Belgium

    M. E. De Broe  & G. A. Verpooten  & 

  2. Department of Medicine, The Oregon Health Sciences University, Portland, Oregon, 97201, USA

    G. A. Porter

  3. Division of Nephrology, The Oregon Health Sciences University, Portland, Oregon, 97201, USA

    W. M. Bennett

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Kunis, C.L., Appel, G.B. (1998). Renal disease associated with illicit drug abuse. In: De Broe, M.E., Porter, G.A., Bennett, W.M., Verpooten, G.A. (eds) Clinical Nephrotoxins. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9088-4_31

Download citation

  • DOI: https://doi.org/10.1007/978-94-015-9088-4_31

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-015-9090-7

  • Online ISBN: 978-94-015-9088-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation